Basic categories | Placental types | Placental size | Dominant villi | Villous Thy-1 | Dilatation of sinusoids | cE LMW variants | ERα protein expression |
---|
NP, ERα+ | PT1a | Normal | mature | high | low | all low | strong |
 | PT2b | Normal | mature | moderate | moderate | all higher vs. PT1 | strong |
AP, ERα- | PT3c | Normal | aged | low | excessive | some higher | traces |
 | PT4Ad | Hypertrophy | young | traces | low | some higher | traces |
 | PT4Be | Atrophy | immature | traces | low | some higher | traces |
- aPT1, normal placental type, with occasional development of new mature villi or expansion of existing villi to fulfill the demands of the progressively growing fetus. Rarely, if there is no requirement for villous replacement or expansion, the ERα might not be expressed. bPT2, marginal irregularity, which can be interpreted as a compensation of imminent placental aging by enhanced development of new villi associated with expansion of existing mature villi and moderate dilatation of villous sinusoids. cPT3, placental senescence associated with the extreme dilatation of villous blood sinusoids and no compensatory villous development or expansion. dPT4A, placental hypertrophy – terminal villi persist in a young/immature state with compensatory development of additional young terminal villi (maternal diabetes mellitus associated with fetal macrosomia). ePT4B, placental atrophy – terminal villi persist in a young/immature state without compensatory development of additional young terminal villi (intrauterine growth retardation and poor Apgars).